Activation of tumor initiating cells during anti-angiogenic therapies promotes tumor progression and relapse formation in hepatocellular carcinoma

Authors :: D Becker
Carolin Czauderna
Peter P. Grimminger
Hauke Lang
D Castven
MA Wörns
Jens U. Marquardt
Peter R. Galle
Snorri S. Thorgeirsson
Source :: Zeitschrift für Gastroenterologie. 54:1343-1404
Publication Year :: 2016
Publisher :: Georg Thieme Verlag KG, 2016.

Subjects :: Tumor progression
business.industry
Hepatocellular carcinoma
Anti angiogenic
Immunology
Gastroenterology
Cancer research
medicine
medicine.disease
business
Tumor Initiating Cells

Full Text Access

Tools